Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

9 treatments under study, led by Cyclosporine

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Phase 1/2 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT00579527Phase 1/2Completed

Phase I/II Thymus Transplantation With Immunosuppression #950

Showing all 1 trials

Research Network

Common Treatments

  • Cyclosporine1
  • Cultured Thymus Tissue For Implantation Ctti1
  • Rabbit Antithymocyte Globulin1
  • Daclizumab1
  • Tacrolimus1

Active Sponsors

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
  • Sumitomo Pharma Switzerland GmbH1
  • National Institute of Allergy and Infectious Diseases (NIAID)1
  • National Institutes of Health (NIH)1

Top Investigators

Related Conditions

  • Complete Digeorge Syndrome1
  • Complete Digeorge Anomaly1
  • Complete Atypical Digeorge Anomaly1
  • Digeorge Anomaly1

Activity Timeline